Ontology highlight
ABSTRACT: Background
Studies reporting collective and comprehensive data on plaque regression of different lipid-lowering therapies (LLTs) are limited.Objectives
We evaluated plaque regression of LLTs based on multiple markers and performed subgroup analyses based on LLT type and post-treatment LDL-C levels.Methods
A literature search was performed to identify studies assessing plaque regression from LLTs. The following LLTs groups were included: High-intensity statin (HIS), HIS+ eicosapentaenoic acid (EPA), HIS + ezetimibe, Low-intensity statin (LIS), LIS + EPA, LIS + Ezetimibe, and PCSK9 inhibitors. Our primary outcomes were change in percent atheroma volume (PAV). Secondary outcomes included mean differences in total atheroma volume (TAV), lumen, plaque, and vessel volumes
SUBMITTER: Rivera FB
PROVIDER: S-EPMC10966153 | biostudies-literature | 2024 Jun
REPOSITORIES: biostudies-literature